Most lately, it's been determined that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds into a wide array of endogenous opioids. In contrast to most opioid receptors, this receptor acts like a scavenger and would not activate a next m… Read More